The University of Oregon launching a new apparel line to support cancer research and awareness, OHSU's Emily Larson, M.D., says, “Seeing such a beloved sports team use their platform to support cancer awareness is truly inspiring. It reminds patients and survivors that they have an entire community behind them.”

Continued news coverage of an OHSU-led study that suggests initial placement of defibrillators can make a significant difference in returning spontaneous blood circulation for patients in cardiac arrest.

The New York Times covers routine screening methods for colon cancer. David Lieberman, M.D., weighs in on why many physicians prefer colonoscopies over fecal tests: “The idea of finding and removing cancer precursor lesions became very attractive to physicians.”

BridgeBio announces in a Globe Newswire release that Ahmad Masri, M.D., will present on advances in prognostication and management of cardiac amyloidosis on Nov. 17 during an American Heart Association conference in Chicago.

Highlights from the 2024 American Association for Cancer Research special conference on pancreatic cancer research include a presentation from Teresa Zimmers, Ph.D., who provided a review of preclinical research into inflammation and cachexia.

HemOnc Today interviews Eric Roeland, M.D., about a recent New England Journal of Medicine publication highlighting positive findings from a phase II clinical trial for patients with cachexia. Roeland says, “We had 10 participants at our site and, early on in the study, I could tell there was something different happening. This is an exciting first step toward an intervention that may have profound implications on how we support patients as people going through their cancer treatment.”

Annie Hung, M.D., speaks with KOIN-TV about the importance of screening and early detection for patients with breast cancer. She says, “For Stage 1 breast cancer, the overall survival rate can be over 99% for a five-year period. These patients can be cured, and the long-term outcome is excellent. During the pandemic, unfortunately, we did have a lot of people who missed out on their screenings. And so we are seeing people diagnosed at more advanced stages.”

A team of OHSU surgeons this year performed the region’s first fetoscopic repair for spina bifida, which can significantly improve long-term health outcomes for babies born with the condition.

Life Flight, owned by a consortium that includes OHSU, announces in a PR Newswire release that it has installed a special oxygen delivery system in one of its fixed-wing airplanes.

New OHSU research illuminates the complete structure of a protein linked to health issues ranging from cancer to nerve pain to brain disorders. In an OHSU News story, Steven Mansoor, M.D., Ph.D., says, “We are really interested in understanding how the seven P2X receptor subtypes differ from each other at a molecular level. This is important because if you wanted to design a drug that blocks the activation of P2X7, you do not want to affect the function of other receptors.”